“Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s737, https://doi.org/10.25251/0y59xj91.